Patent Assignment
Reel/Frame 028221/0270
Assignment of Assignor's Interest
Recorded: 2012-05-16
Pages: 8
Assignor
ARYX THERAPEUTICS, INC.
Executed: 2012-03-05
Assignee
ANDAMAN THERAPEUTICS, INC.
230 CALIFORNIA STREET, SUITE 600, SAN FRANCISCO, CALIFORNIA, 94111
Covered Properties
(3)
Dibenzo[B,F][1,4]Oxazapine Compounds
Dibenzo [B,F] [1,4]Oxazapine Compounds
Application:
13/323,183 →
Publication:
US 2012/0178738
DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS
Application:
60/895,046 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 16, 2007
From: BECKER, CYRUS; RUBENS, COURTNEY; ADAMS, JASON; PALME, MONICA
To: ARYX THERAPEUTICS
Reel/Frame 019301/0278 →
Assignment of Assignor's Interest
May 9, 2008
From: BECKER, CYRUS; RUBENS, COURTNEY; ADAMS, JASON; PALME, MONICA
To: ARYX THERAPEUTICS, INC.
Reel/Frame 020927/0850 →
Security Agreement
Oct 18, 2010
From: ARYX THERAPEUTICS, INC.
To: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
Reel/Frame 025150/0379 →
Assignment of Assignor's Interest
Mar 26, 2012
From: BECKER, CYRUS; RUBENS, COURTNEY; ADAMS, JASON; PALME, MONICA
To: ARYX THERAPEUTICS, INC.
Reel/Frame 027927/0375 →
Merger
Jan 8, 2016
From: ANDAMAN THERAPEUTICS, INC.; ALPINE BIOSCIENCES, LLC
To: ALPINE BIOSCIENCES, INC.
Reel/Frame 037443/0316 →
Merger
Jan 8, 2016
From: AB ACQUISITION; ALPINE BIOSCIENCES, INC.
To: ALPINE BIOSCIENCES, INC.
Reel/Frame 037464/0155 →
Change of Name
Jan 11, 2016
From: ALPINE BIOSCIENCES, INC.
To: PROTOCELL THERAPEUTICS INC.
Reel/Frame 037471/0445 →